Trends in utilization of lipid- and blood pressure-lowering agents and goal attainment among the U.S. diabetic population, 1999-2008

<p>Abstract</p> <p>Background</p> <p>For patients with diabetes, clinical practice guidelines recommend treating to a low-density lipoprotein cholesterol (LDL-C) goal of <2.59 mmol/L (100 mg/dL) and a blood pressure (BP) target of <130/80 mmHg. This analysis asses...

Full description

Bibliographic Details
Main Authors: Kuznik Andreas, Mardekian Jack
Format: Article
Language:English
Published: BMC 2011-04-01
Series:Cardiovascular Diabetology
Online Access:http://www.cardiab.com/content/10/1/31
_version_ 1811286894265237504
author Kuznik Andreas
Mardekian Jack
author_facet Kuznik Andreas
Mardekian Jack
author_sort Kuznik Andreas
collection DOAJ
description <p>Abstract</p> <p>Background</p> <p>For patients with diabetes, clinical practice guidelines recommend treating to a low-density lipoprotein cholesterol (LDL-C) goal of <2.59 mmol/L (100 mg/dL) and a blood pressure (BP) target of <130/80 mmHg. This analysis assessed recent trends in the utilization of lipid-lowering and BP-lowering agents, as well as LDL-C and BP goal attainment, in the U.S. adult diabetic population.</p> <p>Methods</p> <p>9,167 men and nonpregnant women aged ≥20 years were identified from the fasting subsample of the 1999-2008 National Health and Nutritional Examination Survey. Diabetes was identified in 1,214 participants by self report, self-reported use of insulin or oral medications for diabetes, or fasting glucose ≥6.99 mmol/L (126 mg/dL).</p> <p>Results</p> <p>The prevalence of diagnosed or undiagnosed diabetes increased significantly over the past decade, from 7.4% in 1999-2000 to 11.9% in 2007-2008 (<it>P </it>= 0.0007). During this period, the use of lipid-lowering agents by participants with diabetes increased from 19.5% to 42.2% (<it>P </it>< 0.0001), and the proportion at LDL-C goal increased from 29.7% to 54.4% (<it>P </it>< 0.0001). Although there was a significant increase in antihypertensive medication use (from 35.4% to 58.9%; <it>P </it>< 0.0001), there was no significant change in the proportion of participants at BP goal (from 47.6% to 55.1%; <it>P </it>= 0.1333) or prevalence of hypertension (from 66.6% to 74.2%; <it>P </it>= 0.3724).</p> <p>Conclusions</p> <p>The proportion of diabetic individuals taking lipid- and BP-lowering agents has increased significantly in recent years. However, while there has been a significant improvement in LDL-C goal attainment, nearly one-half of all U.S. adults with diabetes are not at recommended LDL-C or BP treatment goals.</p>
first_indexed 2024-04-13T03:09:06Z
format Article
id doaj.art-cb0c3c28c36c46f8b67ca6a1e61d16e8
institution Directory Open Access Journal
issn 1475-2840
language English
last_indexed 2024-04-13T03:09:06Z
publishDate 2011-04-01
publisher BMC
record_format Article
series Cardiovascular Diabetology
spelling doaj.art-cb0c3c28c36c46f8b67ca6a1e61d16e82022-12-22T03:05:09ZengBMCCardiovascular Diabetology1475-28402011-04-011013110.1186/1475-2840-10-31Trends in utilization of lipid- and blood pressure-lowering agents and goal attainment among the U.S. diabetic population, 1999-2008Kuznik AndreasMardekian Jack<p>Abstract</p> <p>Background</p> <p>For patients with diabetes, clinical practice guidelines recommend treating to a low-density lipoprotein cholesterol (LDL-C) goal of <2.59 mmol/L (100 mg/dL) and a blood pressure (BP) target of <130/80 mmHg. This analysis assessed recent trends in the utilization of lipid-lowering and BP-lowering agents, as well as LDL-C and BP goal attainment, in the U.S. adult diabetic population.</p> <p>Methods</p> <p>9,167 men and nonpregnant women aged ≥20 years were identified from the fasting subsample of the 1999-2008 National Health and Nutritional Examination Survey. Diabetes was identified in 1,214 participants by self report, self-reported use of insulin or oral medications for diabetes, or fasting glucose ≥6.99 mmol/L (126 mg/dL).</p> <p>Results</p> <p>The prevalence of diagnosed or undiagnosed diabetes increased significantly over the past decade, from 7.4% in 1999-2000 to 11.9% in 2007-2008 (<it>P </it>= 0.0007). During this period, the use of lipid-lowering agents by participants with diabetes increased from 19.5% to 42.2% (<it>P </it>< 0.0001), and the proportion at LDL-C goal increased from 29.7% to 54.4% (<it>P </it>< 0.0001). Although there was a significant increase in antihypertensive medication use (from 35.4% to 58.9%; <it>P </it>< 0.0001), there was no significant change in the proportion of participants at BP goal (from 47.6% to 55.1%; <it>P </it>= 0.1333) or prevalence of hypertension (from 66.6% to 74.2%; <it>P </it>= 0.3724).</p> <p>Conclusions</p> <p>The proportion of diabetic individuals taking lipid- and BP-lowering agents has increased significantly in recent years. However, while there has been a significant improvement in LDL-C goal attainment, nearly one-half of all U.S. adults with diabetes are not at recommended LDL-C or BP treatment goals.</p>http://www.cardiab.com/content/10/1/31
spellingShingle Kuznik Andreas
Mardekian Jack
Trends in utilization of lipid- and blood pressure-lowering agents and goal attainment among the U.S. diabetic population, 1999-2008
Cardiovascular Diabetology
title Trends in utilization of lipid- and blood pressure-lowering agents and goal attainment among the U.S. diabetic population, 1999-2008
title_full Trends in utilization of lipid- and blood pressure-lowering agents and goal attainment among the U.S. diabetic population, 1999-2008
title_fullStr Trends in utilization of lipid- and blood pressure-lowering agents and goal attainment among the U.S. diabetic population, 1999-2008
title_full_unstemmed Trends in utilization of lipid- and blood pressure-lowering agents and goal attainment among the U.S. diabetic population, 1999-2008
title_short Trends in utilization of lipid- and blood pressure-lowering agents and goal attainment among the U.S. diabetic population, 1999-2008
title_sort trends in utilization of lipid and blood pressure lowering agents and goal attainment among the u s diabetic population 1999 2008
url http://www.cardiab.com/content/10/1/31
work_keys_str_mv AT kuznikandreas trendsinutilizationoflipidandbloodpressureloweringagentsandgoalattainmentamongtheusdiabeticpopulation19992008
AT mardekianjack trendsinutilizationoflipidandbloodpressureloweringagentsandgoalattainmentamongtheusdiabeticpopulation19992008